Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1416564-35-6

Post Buying Request

1416564-35-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1416564-35-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1416564-35-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,6,5,6 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1416564-35:
(9*1)+(8*4)+(7*1)+(6*6)+(5*5)+(4*6)+(3*4)+(2*3)+(1*5)=156
156 % 10 = 6
So 1416564-35-6 is a valid CAS Registry Number.

1416564-35-6Downstream Products

1416564-35-6Relevant articles and documents

Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors

Pasquini, Serena,De Rosa, Maria,Ligresti, Alessia,Mugnaini, Claudia,Brizzi, Antonella,Caradonna, Nicola P.,Cascio, Maria Grazia,Bolognini, Daniele,Pertwee, Roger G.,Di Marzo, Vincenzo,Corelli, Federico

, p. 30 - 43 (2013/02/22)

Within our studies on structure-activity relationships of 4-quinolone-3-carboxamides as cannabinoid ligands, a new series of compounds characterized by a fluoro or phenylthio group at 7-position and different substituents at N1 and carboxamide nitrogen were synthesized and evaluated for their binding ability to cannabinoid type 1 (CB1) and type 2 (CB2) receptors. Most of the compounds showed affinity for one or both cannabinoid receptors at nanomolar concentration, with Ki(CB1) and Ki(CB2) values ranging from 2.45 to >10,000 nM and from 0.09 to 957 nM, respectively. The N-(3,4-dichlorobenzyl)amide derivatives 27 and 40 displayed relatively low affinity, but high selectivity towards the CB1 receptor. Compounds 4 and 40, a CB2 and a CB1 ligand, respectively, behaved as partial agonists in the [ 35S]GTPγS assay. They showed very low permeability through (MDCK-MDR1) cells and might, therefore, represent possible lead structures for further optimization in the search for cannabinoid ligands unable to cross the blood-brain barrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1416564-35-6